
Sign up to save your podcasts
Or


Send us a text
This week, SurfingNASH offers an episode comprising two seperate interviews which focus on stories around career trajectories, transitions and entrepreneurship. Host Roger Green talks with Rachel Zayas (AGED Diagnostics) and Michelle Long (Novo Nordisk) about their unique stories and creating new opportunities amidst a field with broadening but sometimes opaque horizons. These discussions will be very informative for those who may be wondering about what's on the other side, whether it be commercial medicine or academia. Surf on to learn more as Rachel and Michelle expand on bridging these gaps, managing challenges and their excitement for new ways forward.
This first conversation features a section of the interview with Rachel. While we originally planned for the interview to be largely about fundraising and what it takes to win new venture competitions, it didn’t quite turn out that way. After an initial question about fundraising, the two quickly refocus on Rachel’s product development process and the clinical trial work she is doing in preparation for market. Along the way, she describes the thinking behind designing her basic trial specifications and the sequential steps she has taken toward the 2,000 that will be her pivotal effort in obtaining approvals and coming to market.
If you have questions or comments around these interviews or any of the topics discussed in this episode, we kindly ask that you submit reviews wherever you download the discourse. Alternatively, you can write to us directly at [email protected].
Stay Safe and Surf On!
By SurfingNASH.com3.9
2424 ratings
Send us a text
This week, SurfingNASH offers an episode comprising two seperate interviews which focus on stories around career trajectories, transitions and entrepreneurship. Host Roger Green talks with Rachel Zayas (AGED Diagnostics) and Michelle Long (Novo Nordisk) about their unique stories and creating new opportunities amidst a field with broadening but sometimes opaque horizons. These discussions will be very informative for those who may be wondering about what's on the other side, whether it be commercial medicine or academia. Surf on to learn more as Rachel and Michelle expand on bridging these gaps, managing challenges and their excitement for new ways forward.
This first conversation features a section of the interview with Rachel. While we originally planned for the interview to be largely about fundraising and what it takes to win new venture competitions, it didn’t quite turn out that way. After an initial question about fundraising, the two quickly refocus on Rachel’s product development process and the clinical trial work she is doing in preparation for market. Along the way, she describes the thinking behind designing her basic trial specifications and the sequential steps she has taken toward the 2,000 that will be her pivotal effort in obtaining approvals and coming to market.
If you have questions or comments around these interviews or any of the topics discussed in this episode, we kindly ask that you submit reviews wherever you download the discourse. Alternatively, you can write to us directly at [email protected].
Stay Safe and Surf On!

32,317 Listeners

30,871 Listeners

9,737 Listeners

105 Listeners

21,268 Listeners

3,377 Listeners

113,207 Listeners

57,056 Listeners

9,582 Listeners

8,718 Listeners

10,275 Listeners

6,466 Listeners

0 Listeners

418 Listeners

680 Listeners